Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction

Background: The management of acute myocardial infarction (AMI) presents several challenges in patients with diabetes, among them the higher rate of recurrent thrombotic events, hyperglycemia and risk of subsequent heart failure (HF). The objective of our study was to evaluate effects of DPP-4 inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Genestreti, Paulo R. Rizzo, Furtado, Remo H. M., Salsoso, Rocio, Dalçóquio, Talia F., Franci, Andre, Menezes, Fernando R., Caporrino, Cesar, Ferrari, Aline G., Nakashima, Carlos A. K., Scanavini Filho, Marco A., Lima, Felipe G., Giraldez, Roberto R. C. V., Baracioli, Luciano M., Nicolau, Jose C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571017/
https://www.ncbi.nlm.nih.gov/pubmed/36233642
http://dx.doi.org/10.3390/jcm11195776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571017/
https://www.ncbi.nlm.nih.gov/pubmed/36233642
http://dx.doi.org/10.3390/jcm11195776

Ejemplares similares